EBRD lends €10 million to Aversi Pharma in Georgia

• EBRD helping Aversi Pharma to establish a modern, energy efficient pharmaceutical warehouse
• Project expected to deliver energy savings of up to 40 per cent through advanced design and automation
• Investment will boost competitiveness and skills in Georgia’s pharmaceutical sector

The European Bank for Reconstruction and Development (EBRD) is strengthening its support for green and competitive private-sector development in Georgia with a loan of up to €10 million for Aversi Pharma, one of the country’s leading pharmaceutical and healthcare companies.

This financing will support the renovation and automation of a newly acquired central warehouse in Tbilisi, helping Aversi Pharma to modernise its logistics infrastructure and consolidate its operations into a large, state-of-the-art facility compliant with international good distribution practices.

The project is fully aligned with the EBRD’s Green Economy Transition (GET) approach and is classified as 100 per cent green. The new warehouse is expected to deliver significant energy efficiency gains of up to 40 per cent, driven by its advanced design and modern automation technologies. The introduction of automated conveyors, robotics and warehouse management systems will also optimise the utilisation of space and reduce the overall carbon footprint of operations.

By helping to establish one of Georgia’s first highly automated pharmaceutical logistics centres, the investment will enhance efficiency, reliability and supply-chain resilience in the pharmaceutical sector, contributing to improved availability of medicines across the country.

The EBRD is also supporting the development of workforce skills in the pharmaceutical industry through a dedicated technical cooperation programme. This will include the creation of new digital training programmes and an e-learning platform, benefiting at least 1,000 employees and fostering more inclusive access to skills development, including for underrepresented ethnic groups.

Aversi Pharma, a longstanding EBRD client, is a major player in Georgia’s pharmaceutical and healthcare sector, operating one of the country’s largest pharmacy chains and an extensive network of hospitals and medical centres. The company plays a critical role in ensuring access to essential medicines and healthcare services nationwide.

Since it started operating in Georgia in 1996, the EBRD has invested nearly €5.8 billion in the country across 318 projects, supporting the private sector, financial institutions and sustainable economic development.